Abstract

Intermittent fasting (IF) refers to various dietary regimens that cycle between a period of non-fasting and a period of total fasting. This study aimed to determine the effects of IF on cognitive function among elderly individuals who practice IF who have mild cognitive impairment (MCI). A total of 99 elderly subjects with MCI of Malay ethnicity without any terminal illness were recruited from a larger cohort study, LRGS TUA. The subjects were divided into three groups, comprising those who were regularly practicing IF (r-IF), irregularly practicing IF (i-IF), and non-fasters (n-IF). Upon 36 months of follow-up, more MCI subjects in the r-IF group reverted to successful aging with no cognitive impairment and diseases (24.3%) compared to those in i-IF (14.2%) and n-IF groups (3.7%). The r-IF group’s subjects exhibited significant increment in superoxide dismutase (SOD) activity and reduction in body weight, levels of insulin, fasting blood glucose, malondialdehyde (MDA), C-reactive protein (CRP), and DNA damage. Moreover, metabolomics analysis showed that IF may modulate cognitive function via various metabolite pathways, including the synthesis and degradation of ketone bodies, butanoate metabolism, pyruvate metabolism, and glycolysis and gluconeogenesis pathways. Overall, the MCI-afflicted older adults who practiced IF regularly had better cognitive scores and reverted to better cognitive function at 36 months follow-up.

Highlights

  • Neurodegenerative diseases, a heterogeneous group of disorders, are characterized by slow progressive loss of neurons [1]

  • The study found that 88.9% of subjects who do not practice Intermittent fasting (IF) (n-IF) had less than 6 years of education

  • The n-IF group showed a significantly lower number of years of education when compared to the regularly practicing IF (r-IF) group (p < 0.05)

Read more

Summary

Introduction

Neurodegenerative diseases, a heterogeneous group of disorders, are characterized by slow progressive loss of neurons [1]. The precise etiology underlying neurodegeneration has not been fully elucidated, oxidative stress has been suggested as one of the contributing factors of various neurodegenerative diseases and accelerated aging [2,3,4,5]. Levels of oxidative damage correlate significantly with the neurodegenerative impairment in various populations. For these reasons, there is a great. Nutrients 2020, 12, 2644 interest among researchers in finding ways to protect against oxidative damage and potentially treat neurodegenerative diseases, especially among individuals with mild cognitive impairment (MCI). Previous research has reported that MCI is associated with impairment of glucose metabolism in the brain, dietary composition, and caloric intake [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call